SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,591,000 | -4.8% | 409,912 | -6.5% | 0.04% | -9.8% |
| Q2 2017 | $4,825,000 | +11.0% | 438,607 | -1.1% | 0.04% | +10.8% |
| Q1 2017 | $4,347,000 | -10.0% | 443,541 | -0.9% | 0.04% | -5.1% |
| Q4 2016 | $4,832,000 | -25.1% | 447,452 | -28.9% | 0.04% | -22.0% |
| Q3 2016 | $6,453,000 | -21.5% | 629,530 | 0.0% | 0.05% | -28.6% |
| Q2 2016 | $8,222,000 | +17.2% | 629,530 | -1.3% | 0.07% | +4.5% |
| Q1 2016 | $7,017,000 | +17.4% | 637,937 | -1.8% | 0.07% | +15.5% |
| Q4 2015 | $5,979,000 | +29.4% | 649,853 | -2.4% | 0.06% | +20.8% |
| Q3 2015 | $4,620,000 | -43.1% | 665,689 | -19.5% | 0.05% | -52.0% |
| Q2 2015 | $8,116,000 | +34.2% | 826,481 | +21.0% | 0.10% | +44.9% |
| Q1 2015 | $6,049,000 | -0.4% | 682,781 | -1.6% | 0.07% | -1.4% |
| Q4 2014 | $6,076,000 | +8338.9% | 693,581 | +4683.3% | 0.07% | +2233.3% |
| Q2 2013 | $72,000 | – | 14,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |